CytoSorbents (NSDQ:CTSO) announced today that it enrolled the first patient in a trial of its STAR-T trial for the DrugSorb-ATR system. Monmouth Junction, New Jersey-based CytoSorbents designed its DrugSorb-ATR antithrombotic removal system for the intraoperative removal of ticagrelor during cardiothoracic surgery. According to a CytoSorbents news release, the STAR-T (Safe and Timely Antithrombotic Removal-Ticagrelor) double-blind, […]